Refractory B-cell small lymphocytic lymphoma

Clinical trials for Refractory B-cell small lymphocytic lymphoma explained in plain language.

Never miss a new study

Get alerted when new Refractory B-cell small lymphocytic lymphoma trials appear

Sign up with your email to follow new studies for Refractory B-cell small lymphocytic lymphoma, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Supercharged immune cells take on tough B-Cell cancers in early trial

Disease control Ongoing

This early-phase trial tests a new cell therapy called ANCHOR for people with B-cell lymphoma or leukemia that has returned or not responded to treatment. The therapy uses immune cells from a healthy donor that are engineered to recognize and attack cancer cells carrying the CD19…

Matched conditions: REFRACTORY B-CELL SMALL LYMPHOCYTIC LYMPHOMA

Phase 1 • Sponsor: Baylor College of Medicine • Aim: Disease control

Last updated Jul 15, 2026 00:00 UTC

Refractory B-cell small lymphocytic lymphoma

Get alerted when new Refractory B-cell small lymphocytic lymphoma trials appear

Supercharged immune cells take on tough B-Cell cancers in early trial